Table: Kobayashi Pharmaceutical -Q1 group results

Kobayashi Pharmaceutical

09/05/2025 07:34

May 9 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2025        Mar 31, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             32.61               36.49           171.00    
                 (-10.6 pct)         (+9.0 pct)       (+3.3 pct)  
  Operating          2.54                5.03            14.00    
                 (-49.6 pct)         (-0.6 pct)       (-43.7 pct) 
  Recurring          2.40                5.46            15.30    
                 (-56.0 pct)         (+5.7 pct)       (-43.0 pct) 
  Net                1.62              976 mln           10.50    
                 (+66.5 pct)         (-72.9 pct)      (+4.3 pct)  
  EPS             21.86 yen           13.13 yen       141.25 yen  
  Ann Div                            102.00 yen       104.00 yen  
  -Q2 div                             43.00 yen        44.00 yen  
  -Q4 div                             59.00 yen        60.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T